Review of early stage bc and adjuvant therapy
Currently, UpToDate indicates that presently well over 50% of patients diagnosed with bc are over the age of 65. Most patients deal with menopausal changes starting around age 45, which makes the group of bc patients who are menopausal or postmenopausal at time of diagnosis even much larger.
Younger patients are a fairly small group among breast cancer patients, and premenopausal.
In addition, the majority of breast cancer patients are being diagnosed much earlier than in the past, with early stage breast cancer.
Consider the question of the value of application of chemotherapy for the vast majority of breast cancer patients, given the characteristics noted above, with the information in this May, 2011 article:
http://www.nature.com/nrclinonc/jour...c.2011.19.html
__________________
Dx 2002 age 51
bc for granny, aunt, cousin, sister, mother.
ER+/PR+/HER2+++, grade 3
IDC 1.9 cm, some DCIS, Stage 1, Grade 3
Lumpectomy, CAFx6 (no blood boosters), IMRT rads, 1 3/4 yr tamoxifen
Rads necrosis
BRCA 1 & 2 negative
Trials: Early detection OVCA; 2004 low-dose testosterone for bc survivors
Diet: Primarily vegetarian organic; metformin (no diabetes), vitamin D3
Exercise: 7 days a week, 1 hr/day
No trastuzumab, no taxane, no AI
NED
|
Threaded Mode